Antonio Carlos Rosário Vallinoto Selected Research

Mannose-Binding Lectin (Mannan-Binding Lectin)

5/2021	Pathogenesis of HTLV-1 infection and progression biomarkers: An overview.
10/2019	Influence of Immunogenetic Biomarkers in the Clinical Outcome of HTLV-1 Infected Persons.
5/2014	Mannose-binding lectin and susceptibility to human retrovirus infections.
1/2011	Characterization of mannose-binding lectin plasma levels and genetic polymorphisms in HIV-1-infected individuals.
3/2006	Mannose-binding lectin gene polymorphism and its impact on human immunodeficiency virus 1 infection.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Antonio Carlos Rosário Vallinoto Research Topics

Disease

31	Infections 01/2024 - 03/2006
9	COVID-19 04/2024 - 05/2021
6	Fibrosis (Cirrhosis) 01/2021 - 01/2015
5	Persistent Infection 12/2022 - 01/2016
5	Virus Diseases (Viral Diseases) 09/2022 - 01/2020
4	Post-Acute COVID-19 Syndrome 01/2024 - 01/2023
4	Tuberculosis (Tuberculoses) 10/2023 - 01/2022
4	Disease Progression 03/2023 - 01/2016
4	Sexually Transmitted Diseases (Sexually Transmitted Disease) 10/2022 - 01/2021
4	Chronic Hepatitis C 09/2022 - 01/2020
4	Inflammation (Inflammations) 01/2020 - 01/2016
3	Viremia 03/2023 - 02/2019
3	HIV Infections (HIV Infection) 01/2022 - 11/2018
3	Epstein-Barr Virus Infections 01/2022 - 01/2021
3	Chronic Hepatitis B 01/2022 - 02/2019
3	Liver Diseases (Liver Disease) 11/2021 - 01/2015
2	Cytokine Release Syndrome 04/2024 - 01/2023
2	Bites and Stings (Sting) 01/2024 - 01/2021
2	Extrapulmonary Tuberculosis 01/2023 - 10/2022
2	Chronic Hepatitis (Chronic Active Hepatitis) 01/2022 - 01/2016
2	Coinfection 01/2022 - 01/2021
2	Spinal Cord Diseases 01/2022 - 11/2020
2	Tropical Spastic Paraparesis (Tropical Spastic Paraplegia) 02/2021 - 11/2020
2	Liver Cirrhosis (Hepatic Cirrhosis) 01/2020 - 01/2015
1	Latent Tuberculosis 10/2023
1	Latent Infection 10/2023
1	Acquired Immunodeficiency Syndrome (AIDS) 03/2023
1	Bacterial Infections (Bacterial Infection) 01/2023
1	Pneumonia (Pneumonitis) 01/2023
1	Pulmonary Tuberculosis 01/2023
1	Thrombophilia 01/2023
1	Nephritis 12/2022
1	Hepatitis C 01/2022
1	Deltaretrovirus Infections (BLV Infection) 01/2022
1	Hepatitis 01/2022
1	Chronic Pain 01/2022
1	Neoplasms (Cancer) 11/2021
1	Chronic Disease (Chronic Diseases) 11/2021
1	Neurodegenerative Diseases (Neurodegenerative Disease) 02/2021
1	Papillomavirus Infections 01/2021
1	Autoimmune Diseases (Autoimmune Disease) 07/2020
1	Sickle Cell Anemia (Hemoglobin S Disease) 01/2020

Drug/Important Bio-Agent (IBA)

18	CytokinesIBA 04/2024 - 01/2016
8	Interleukin-6 (Interleukin 6)IBA 01/2024 - 01/2016
7	Biomarkers (Surrogate Marker)IBA 03/2023 - 11/2020
6	Proteins (Proteins, Gene)FDA Link 01/2023 - 02/2019
6	Immunoglobulin G (IgG)IBA 01/2023 - 05/2018
6	Interleukin-10 (Interleukin 10)IBA 01/2023 - 01/2016
5	AntibodiesIBA 01/2023 - 10/2007
5	Mannose-Binding Lectin (Mannan-Binding Lectin)IBA 05/2021 - 03/2006
3	Interleukin-4 (Interleukin 4)IBA 10/2023 - 01/2022
3	Antinuclear AntibodiesIBA 06/2023 - 07/2020
3	C-Reactive ProteinIBA 01/2023 - 01/2016
3	VaccinesIBA 01/2022 - 05/2018
3	Immunoglobulin M (IgM)IBA 01/2022 - 05/2018
3	EnzymesIBA 01/2022 - 12/2017
3	Interleukin-8 (Interleukin 8)IBA 11/2021 - 01/2016
3	Fas Ligand Protein (Fas Ligand)IBA 05/2021 - 01/2016
3	Messenger RNA (mRNA)IBA 01/2020 - 01/2015
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 04/2024 - 05/2021
2	Interleukin-17 (Interleukin 17)IBA 05/2023 - 01/2022
2	Interleukin-2 (IL2)IBA 05/2023 - 01/2022
2	AutoantibodiesIBA 09/2022 - 07/2020
2	Nerve Growth Factor (NGF)IBA 01/2022 - 01/2015
2	InterferonsIBA 05/2021 - 01/2016
2	InterleukinsIBA 05/2021 - 01/2016
2	KIR ReceptorsIBA 05/2021 - 10/2019
2	Immunoglobulins (Immunoglobulin)IBA 05/2021 - 10/2019
2	Illicit Drugs (Recreational Drugs)IBA 01/2021 - 01/2021
2	Antiviral Agents (Antivirals)IBA 01/2021 - 01/2021
2	AntigensIBA 01/2021 - 10/2019
2	Transaminases (Aminotransferases)IBA 01/2021 - 01/2017
1	Interferon-gamma (Interferon, gamma)IBA 04/2024
1	Chemokine CXCL12IBA 03/2023
1	fibrin fragment D (D-dimer)IBA 01/2023
1	Ferritins (Ferritin)IBA 01/2023
1	Genetic Markers (Genetic Marker)IBA 01/2023
1	Nucleocapsid ProteinsIBA 01/2023
1	Immunosuppressive Agents (Immunosuppressants)IBA 12/2022
1	Azathioprine (Imuran)FDA LinkGeneric 12/2022
1	efavirenz (Sustiva)FDA Link 01/2022
1	HLA-B Antigens (HLA-B)IBA 01/2022
1	Monoclonal AntibodiesIBA 11/2021
1	Indoleamine-Pyrrole 2,3,-Dioxygenase (Indoleamine 2,3 Dioxygenase)IBA 11/2021
1	HLA Antigens (Human Leukocyte Antigens)IBA 05/2021
1	Annexin A1IBA 02/2021
1	Interferon Type IIBA 01/2021
1	Integrin alpha ChainsIBA 01/2020
1	Antimitotic AgentsIBA 01/2020
1	three prime repair exonuclease 1IBA 12/2019
1	Blood Proteins (Serum Proteins)IBA 02/2019
1	Peptides (Polypeptides)IBA 11/2018

Therapy/Procedure

5	Therapeutics 03/2023 - 01/2021
4	Condoms (Condom) 12/2022 - 01/2021
2	Art Therapy 06/2023 - 07/2020
2	Highly Active Antiretroviral Therapy (HAART) 01/2022 - 01/2021
2	Activities of Daily Living (ADL) 01/2022 - 11/2020
2	Blood Transfusion (Blood Transfusions) 01/2022 - 01/2020
1	Renal Dialysis (Hemodialysis) 12/2022
1	Immunotherapy 11/2021